Company / Cash per Share
Mirum Pharmaceuticals, Inc. Cash per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$6.14
FY2025
5-year range
$0.92 / $7.75
FY2021-FY2025
Trend
+28.9%
vs FY2024
Sector context
#34 of 205
Health Care
What the data says
Mirum Pharmaceuticals, Inc.'s cash per share of $6.14 is higher than 83% of companies in the Health Care sector (FY2025). Cash per Share has fluctuated over the past 8 years, ranging from $0.92 in FY2022 to $57.78 in FY2018.
Based on SEC 10-K filings.
6.14 in FY2025 with a 5-year CAGR of +1.8%. Top quartile in the Health Care sector.
Declined from $7.75 to $6.14 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +88.5%
- 5-Year CAGR
- +1.8%
- 10-Year CAGR
- -
Sector benchmark
-91.0% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 28.9% year-over-year.
- Ranks #34 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2018.
- Lowest cash per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -26.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.14 | +28.9% |
| FY2024 | $4.76 | -38.5% |
| FY2023 | $7.75 | +746.1% |
| FY2022 | $0.92 | -13.0% |
| FY2021 | $1.05 | -81.3% |
| FY2020 | $5.63 | +439.9% |
| FY2019 | $1.04 | -98.2% |
| FY2018 | $57.78 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026